Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which anesthesia drug calms kids best after tonsil surgery?

NCT ID NCT07433231

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested four different anesthesia drugs in 100 children aged 3-10 having tonsil surgery. The goal was to see which drug best prevents confusion and restlessness after waking up. Researchers measured pain, agitation, and recovery quality in the recovery room.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
magnesium sulfate, propofol, ketamine, lidocaine
What this could lead to
If successful, this could identify the best anesthesia method to reduce post-surgery confusion and pain in children.
What could go wrong
This is a small, completed trial with 100 children. Results may not apply to all hospitals or surgeries. No drug is being developed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Nov 2023

Finished

Mar 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 10 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * pediatric patients aged 3-10 years * American Society of Anesthesiologists (ASA) physical status I-II * scheduled for elective adenotonsillectomy Exclusion Criteria: * ASA III or higher * emergency surgery * communication barriers * history of allergy to any study medication * known cognitive or developmental delay.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenotonsillar hypertrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenoid hypertrophy Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gaziosmanpaşa Training and Research Hospital

    Istanbul, 34075, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.